Randomized Clinical Trial, Open, Multicenter Parallel, no Suspension Inferiority Prophylactic Treatment With Valganciclovir in Kidney Transplant CMV-seropositive Cellular Immunity to Develop CD8 + CMV-specific Treatment After Induction Thymoglobulin.
Clinical trial NCT03123627 · COMPLETED
Trial details
- NCT number
- NCT03123627
- Sponsor
- Maimónides Biomedical Research Institute of Córdoba
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-23
- Primary completion
- 2019-10-21
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.